Evgeny Zaytsev
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Dr. Evgeny Zaytsev is an Independent Director at CalciMedica, Inc., a Managing Partner at Bering Capital LLC and a Managing partner at RMI Partners OOO.
He is on the Board of Directors at CalciMedica, Inc. and NovaDigm Therapeutics, Inc. Dr. Zaytsev was previously employed as an Independent Director by Clearside Biomedical, Inc., a Chairman by InteKrin Therapeutics, Inc., a General Partner by Helix Ventures LLC, a President- Global Technology Symposium by Stanford University, a Partner-Pitch Johnson by Asset Management Co., and a Chief Scientific Officer by Medico-Ecological Institute.
He also served on the board at Aldea Pharmaceuticals, Inc., Epic Sciences, Inc. and Adastra Pharmaceuticals, Inc. He received his MBA from Stanford Graduate School of Business and a doctorate degree from Altai State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC. -.--% | 02/07/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CALCIMEDICA, INC. | Directeur/Membre du Conseil | 02/07/2026 |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Directeur/Membre du Conseil | - |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit.The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Corporate Officer/Principal | - |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC is an active manager. | Fondateur | 01/04/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Président | 01/12/2018 |
| CLEARSIDE BIOMEDICAL | Directeur/Membre du Conseil | 26/09/2018 |
Asset Management Co.
Asset Management Co. Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 30/04/2010 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/03/2004 |
Medico-Ecological Institute
Medico-Ecological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur Technique/Scientifique/R&D | 01/08/2000 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asset Management Co.
Asset Management Co. Investment ManagersFinance Alternative investment manager | Finance |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Health Technology |
Helix Ventures LLC
Helix Ventures LLC Investment ManagersFinance Helix Ventures invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early and late stage transactions. It does not invest in medical equipment, diagnostics, healthcare services or healthcare information technology companies. | Finance |
Clearside Biomedical, Inc.
Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Altai State University
Altai State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Health Technology |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit.The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medico-Ecological Institute
Medico-Ecological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC is an active manager. | Finance |
CalciMedica, Inc.
CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national